Main Article Content
Abstract
The purpose of the study – to determine the level of antibodies (AT) of Ig classes A and G to estradiol (E2), progesterone (P) and benzo[a]pyrene (Bp) in patients with endometriosis of varying severity and establish their threshold values as a risk factor for the development of external genital endometriosis.
Materials and methods. A retrospective case – control study was conducted. The study included 200 women. Group I – women with external genital endometriosis (n = 100), Group II – patients with tuboperitoneal infertility (n = 100). All patients underwent an immunological study of blood serum, determined levels of steroid hormones (P, E2), antibodies to them and Bp. To identify the threshold levels of AT, a ROC analysis was performed.
Results. In women with external genital endometriosis, significantly higher levels of AT IgA and IgG to E2, P and benzo[a]pyrene were detected, compared with women of group II. The threshold levels of IgA-Bp, IgA-E2 and IgA-P are > 5 UE, IgG-Bp, IgG-E2 > 9 UE and IgG-P > 8 UE. The level of IgG-P in patients with severe forms of endometriosis is statistically significantly higher than in small forms of the disease. In severe forms, there is a tendency to increase other classes of antibodies.
Conclusion. Patients with external genital endometriosis are characterized by higher levels of IgA and IgG to Bp, E2, P. Their threshold values, which are risk factors for developing the disease, have been established.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Giudice LC. Endometriosis. New Engl J of Med. 2010; 362(25): 2389-2398
Carpinello OJ, Sundheimer LW, Alford CE, Taylor RN, DeCherney AH. Endometriosis. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278996/
Buck Louis GM, Peterson CM, Chen Z, Croughan M, Sundaram R, Stanford J et al. Bisphenol A and phthalates and endometriosis: the Endometriosis: Natural History, Diagnosis and Outcomes Study. Fertil Steril. 2013; 100(1): 162-169. e1-2. DOI: 10.1016/j.fertnstert.2013.03.026. Epub 2013 Apr 8
Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS et al. EDC-2: The Endocrine Society’s Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocrine Reviews. 2015; 36(6): E1-E150. DOI: 10.1210/er.2015-1010
Smarr MM, Kannan К, Buck Louis GM. Endocrine disrupting chemicals and endometriosis. Fertil Steril. 2016; 106(4): 959-966. DOI: 10.1016/j.fertnstert.2016.06.034
Ewa B, Danuta M-Š. Polycyclic aromatic hydrocarbons and PAH-related DNA adducts. J Appl Genetics. 2017; 58(3): 321-330. DOI: 10.1007/s13353-016-0380-3. Epub 2016 Dec 12
Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic test. Prev. Vet. Med. 2000; 45(1-2): 23-41
Krasylnikova KS, Polenok YeG, Anosova TP, Kostyanko MV, Goreyeva YuV, Sutulina IM et al. The characteristics of formation of antibodies to xeno- and endobiotics in women with inherent malformation of fetus. Clinical laboratory diagnostics. 2012; (4): 24-25. Russian (Красильникова К.С., Поленок Е.Г., Аносова Т.П., Костянко М.В., Гореева Ю.В., Сутулина И.М. и др. Особенности образования антител к ксено- и эндобиотикам у женщин с врожденными пороками развития плода //Клиническая лабораторная диагностика. 2012. № 4. С. 24-25)
Polenok EG, Anosov MP, Krasilnikova KS, Kostyanko MV, Verzhbitskaya NE, Gurov EA et al. Estimation of antibodies levels to xenoand endobiotics at the patients with breast cancer. Izvestia RAS SamSC. 2012; 14(5-2): 440-443. Russian (Поленок Е.Г., Аносов М.П., Красильникова К.С., Костянко М.В., Вержбицкая Н.Е., Гуров Е.А. и др. Антитела к ксено- и эндобиотикам у больных раком молочной железы //Известия Самарского научного центра РАН. 2012. Т. 14, № 5-2. С. 440-443)
Elizarova NN, Artymuk NV, Polenok EG, Kolesnikova NB, Pavlovskaya DV, Grishkevich EV. Limited meanings of antibodies to estradiol, progesterone and benzo[a]pyrene as a risk factor for premature rupture of membranes in women with preterm pregnancy. Mother and Child in Kuzbass. 2016; (4): 23-27. Russian (Елизарова Н.Н, Артымук Н.В., Поленок Е.Г, Колесникова Н.Б., Павловская Д.В., Гришкевич Е.В. Пороговые значения антител к эстрадиолу, прогестерону и бензо[а]пирену как факторы риска преждевременного излития околоплодных вод при недоношенной беременности //Мать и Дитя в Кузбассе. 2016. № 4. С. 23-27)
Upson K, De Roos AJ, Thompson ML, Sathyanarayana S, Scholes D, Barr DB, Holt VL. Organochlorine pesticides and risk of endometriosis: findings from a population-based case-control study. Environ Health Perspect. 2013; 121(11-12): 1319-1324. DOI: 10.1289/ehp.1306648. Epub 2013 Nov 5
Wang Y, Yu J, Luo X, Wang X, Li M, Wang L, Li D. Abnormal regulation of chemokine TECK and its receptor CCR9 in the endometriotic milieu is involved in pathogenesis of endometriosis by way of enhancing invasiveness of endometrial stromal cells. Cell Mol Immunol. 2010; 7(1): 51-60. DOI: 10.1038/cmi.2009.102
Porpora MG, Medda E, Abballe A, Bolli S, De Angelis I, di Domenico A et al. Endometriosis and organochlorinated environmental pollutants: a case-control study on Italian women of reproductive age. Environ Health Perspect. 2009; 117: 1070-1075. DOI: 10.1289/ehp.0800273. Epub 2009 Mar 31
Martínez-Zamora MA, Mattioli L, Parera J, Abad E, Coloma JL, van Babel B et al. Increased levels of dioxin-like substances in adipose tissue in patients with deep infiltrating endometriosis. Hum Reprod. 2015; 30(5): 1059-1068. DOI: 10.1093/humrep/dev026. Epub 2015 Mar 4
